Leveraging innate cell engagers for lymphoma treatment
European Pharmaceutical Review
DECEMBER 28, 2023
Finally, Andreas looks at the prospects for antibodies that target the innate immune system in treating both haematological malignancies and solid tumours. Many cancer patients, however, lack a functional innate immune system, and do not have enough functional NK cells. Dr Harstrick received his M.D.
Let's personalize your content